Genetic screening for ethnic minorities.
作者信息
Modell M, Modell B
机构信息
Department of Obstetrics and Gynaecology, University College and Middlesex School of Medicine, London.
出版信息
BMJ. 1990 Jun 30;300(6741):1702-4. doi: 10.1136/bmj.300.6741.1702.
Abstract
摘要
相似文献
1
Genetic screening for ethnic minorities.针对少数民族的基因筛查。
BMJ. 1990 Jun 30;300(6741):1702-4. doi: 10.1136/bmj.300.6741.1702.
2
Paediatrics among ethnic minorities. Afro-Caribbean and African families.少数民族中的儿科学。非裔加勒比人和非洲家庭。
Br Med J (Clin Res Ed). 1985 Mar 30;290(6473):984-8. doi: 10.1136/bmj.290.6473.984.
3
4
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰-萨克斯病的孕前风险评估。
Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD010849. doi: 10.1002/14651858.CD010849.pub2.
5
6
HIV and AIDS, other sexually transmitted diseases, and tuberculosis in ethnic minorities in United Kingdom: is surveillance serving its purpose?英国少数族裔中的艾滋病毒与艾滋病、其他性传播疾病及结核病：监测是否发挥了作用？
BMJ. 1997 Jun 14;314(7096):1747-51. doi: 10.1136/bmj.314.7096.1747.
7
Ethnic minorities and the Mental Health Act.
Br J Psychiatry. 2002 Mar;180:198-9. doi: 10.1192/bjp.180.3.198.
8
Carrier parents of Tay Sachs disease and beta-thalassemia.患有泰-萨克斯病和β地中海贫血的携带者父母。
Indian Pediatr. 2005 May;42(5):498-9.
9
Efficacy of a targeted genetic screening program for adolescents.针对青少年的靶向基因筛查项目的效果
Am J Hum Genet. 1996 Oct;59(4):762-3.
10
Stigmatization of carrier status: social implications of heterozygote genetic screening programs.携带者状态的污名化：杂合子基因筛查项目的社会影响
Am J Public Health. 1978 Nov;68(11):1116-20. doi: 10.2105/ajph.68.11.1116.
引用本文的文献
1
Demographic Studies from a National Gaucher Disease Screening Program.
J Genet Couns. 1998 Oct;7(5):385-99. doi: 10.1023/A:1022876631088.
2
A retrospective survey of community based utilization of Tay Sachs screening in Eight New Jersey counties.对新泽西州八个县基于社区的泰-萨克斯病筛查利用情况的回顾性调查。
J Genet Couns. 1994 Jun;3(2):125-31. doi: 10.1007/BF01423174.
3
Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia?在地中海贫血高发地区，对于平均红细胞体积（MCV）大于80飞升的血样，我们是否应该筛查珠蛋白基因突变？
J Clin Pathol. 2001 Apr;54(4):317-20. doi: 10.1136/jcp.54.4.317.
4
Genetic screening for ethnic minorities.针对少数民族的基因筛查。
BMJ. 1990;301(6748):390. doi: 10.1136/bmj.301.6748.390.
5
Medical genetics.医学遗传学
Postgrad Med J. 1991 Jul;67(789):613-31. doi: 10.1136/pgmj.67.789.613.
6
Testing for Huntington's disease.亨廷顿舞蹈症检测
BMJ. 1992 Jun 20;304(6842):1585-6. doi: 10.1136/bmj.304.6842.1585.
本文引用的文献
1
Management of thalassaemia major.重型地中海贫血的管理
Arch Dis Child. 1983 Dec;58(12):1026-30. doi: 10.1136/adc.58.12.1026.
2
Counselling for prenatal diagnosis of sickle cell disease and beta thalassaemia major: a four year experience.镰状细胞病和重型β地中海贫血产前诊断的咨询：四年经验
J Med Genet. 1988 Nov;25(11):769-72. doi: 10.1136/jmg.25.11.769.
Zotero 插件